Filing Details
Seres Therapeutics, Inc. (NASDAQ:MCRB) filed a Form 8-K with the Securities and Exchange Commission on July 08, 2026, disclosing a material event.
8k filedNASDAQ:MCRB
Seres Therapeutics, Inc. (MCRB) Reports Material Event to SEC
Filing Details Seres Therapeutics, Inc. (NASDAQ:MCRB) filed a Form 8-K with the Securities and Exchange Commission on July 08, 2026, disclosing a material event. Market Context…
Market Context
Seres Therapeutics, Inc.'s stock currently trades at $7.14 with a market capitalization of $151.1M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Seres Therapeutics, Inc.'s stock.
All SEC filings for Seres Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View MCRB Stock Page
Frequently Asked Questions
Where can I read MCRB's SEC filings?
Browse all filings on our MCRB SEC filings page.
What types of SEC filings does Seres Therapeutics, Inc. file?
Public companies like Seres Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.